LGNZZ

(LGNZZ)

About (LGNZZ)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Details

Daily high
$0.07
Daily low
$0.07
Price at open
$0.07
52 Week High
$0.07
52 Week Low
$0.01
Market cap
--
Dividend yield
0.00%
Volume
2,000
Avg. volume
104
P/E ratio
--

News

Details

Daily high
$0.07
Daily low
$0.07
Price at open
$0.07
52 Week High
$0.07
52 Week Low
$0.01
Market cap
--
Dividend yield
0.00%
Volume
2,000
Avg. volume
104
P/E ratio
--